Latest Articles

Publication Date
Health leaders order crackdown on unproven fertility treatments - Express & Star

Health leaders order crackdown on unproven fertility treatments Express & Star

Published: Sept. 10, 2025, 10:20 a.m.
Sigmoid colon endometriosis as an uncommon cause of large bowel obstruction: A case report.

Large bowel obstruction (LBO) is most commonly caused by neoplasms, but rare etiologies like endometriosis should be considered, as bowel involvement can mimic other gastrointestinal disorders and lead to obstruction. …

Published: Sept. 10, 2025, midnight
Erastin-induced multi-pathway cell death in endometriosis: a mechanistic and translational narrative review.

This narrative review examines the therapeutic potential of Erastin and its derivatives for endometriosis (EMS) by integrating mechanistic, preclinical, and translational perspectives. We conducted a focused review of literature from …

Published: Sept. 10, 2025, midnight
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them - NewsBreak: Local News & Alerts

9 Endometrial Cancer Treatment Side Effects, and How to Manage Them NewsBreak: Local News & Alerts

Published: Sept. 9, 2025, 3:28 p.m.
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them - Everyday Health

9 Endometrial Cancer Treatment Side Effects, and How to Manage Them Everyday Health

Published: Sept. 9, 2025, 3:15 p.m.
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study - TipRanks

Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study TipRanks

Published: Sept. 7, 2025, 5:31 p.m.
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States.

Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, and out-of-pocket (OOP) cost, among other …

Published: Sept. 7, 2025, midnight
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks

AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks

Published: Sept. 6, 2025, 4:33 a.m.
Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis.

Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) after laparoscopic surgery. …

Published: Sept. 6, 2025, midnight
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - Medical Xpress

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Medical Xpress

Published: Sept. 5, 2025, 4:10 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!